ATE521336T1 - Zusammensetzungen zur tierärztlichen behandlung von mastitis - Google Patents

Zusammensetzungen zur tierärztlichen behandlung von mastitis

Info

Publication number: ATE521336T1
Authority: AT; Austria
Prior art keywords: mastitis; treatment; formulation; oil; present
Prior art date: 2002-12-20

Application number

AT03775738T

Other languages

English (en)

Inventor

Roderick John Jeremiah Dorgan

Original Assignee

Pfizer Ltd

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-20

Filing date

2003-12-08

Publication date

2011-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9950027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE521336(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-12-08 Application filed by Pfizer Ltd, Pfizer filed Critical Pfizer Ltd

2011-09-15 Application granted granted Critical

2011-09-15 Publication of ATE521336T1 publication Critical patent/ATE521336T1/de

Links

239000000203 mixture Substances 0.000 title abstract 8
238000011282 treatment Methods 0.000 title abstract 4
208000004396 mastitis Diseases 0.000 title abstract 3
238000009472 formulation Methods 0.000 abstract 6
241000283690 Bos taurus Species 0.000 abstract 2
238000011321 prophylaxis Methods 0.000 abstract 2
241000124008 Mammalia Species 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
239000003242 anti bacterial agent Substances 0.000 abstract 1
230000003115 biocidal effect Effects 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
229910001385 heavy metal Inorganic materials 0.000 abstract 1
231100000252 nontoxic Toxicity 0.000 abstract 1
230000003000 nontoxic effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Oncology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT03775738T 2002-12-20 2003-12-08 Zusammensetzungen zur tierärztlichen behandlung von mastitis ATE521336T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0229642.4A GB0229642D0 (en)	2002-12-20	2002-12-20	Veterinary compositions for treating mastitis
PCT/IB2003/005825 WO2005051352A1 (en)	2002-12-20	2003-12-08	Veterinary compositions for treating mastitis

Publications (1)

Publication Number	Publication Date
ATE521336T1 true ATE521336T1 (de)	2011-09-15

Family

ID=9950027

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03775738T ATE521336T1 (de)	2002-12-20	2003-12-08	Zusammensetzungen zur tierärztlichen behandlung von mastitis

Country Status (11)

Country	Link
EP (1)	EP1581184B2 (de)
JP (1)	JP2006515865A (de)
AT (1)	ATE521336T1 (de)
AU (2)	AU2003283757C1 (de)
CA (1)	CA2517622C (de)
ES (1)	ES2369769T5 (de)
GB (1)	GB0229642D0 (de)
MY (1)	MY142767A (de)
NZ (1)	NZ541269A (de)
TW (1)	TW200423927A (de)
WO (1)	WO2005051352A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102004054873A1 (de) *	2004-11-12	2006-05-18	Bayer Healthcare Ag	Behandlung von Mastitis
CN104398510B (zh) *	2014-11-03	2016-09-07	郑州百瑞动物药业有限公司	一种奶牛用苄星氯唑西林乳房注入剂及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3252859A (en) †	1962-10-24	1966-05-24	Masti Kure Company Inc	Colloidal silica-oil composition and method of using same
GB1441747A (en) †	1972-10-18	1976-07-07	Lazonby B	Veterinary compositions
GB1455296A (en) †	1973-05-24	1976-11-10	Beecham Group Ltd	Veterinary treatment
DD110569A1 (de) †	1974-02-22	1974-12-20
CA1052697A (en) *	1974-03-29	1979-04-17	Upjohn Company (The)	Composition for treating mastitis in animals
US4011312A (en) †	1975-06-25	1977-03-08	American Home Products Corporation	Prolonged release drug form for the treatment of bovine mastitis
GB1547164A (en) †	1975-08-14	1979-06-06	Beecham Group Ltd	Veterinary compositions
DE2740887A1 (de) †	1977-09-10	1979-03-22	Bayer Ag	Mittel zur bekaempfung von pflanzenbakteriosen
GB8629481D0 (en) *	1986-12-10	1987-01-21	Beecham Group Plc	Veterinary treatment
US5211961A (en)	1990-08-30	1993-05-18	Louisiana State University Board Of Supervisors	Composition, and method, for premilking udder hygiene
GB2273441B (en) *	1992-12-08	1997-01-08	Bimeda Res Dev Ltd	Veterinary compositions for treating mastitis
US5529770A (en)	1994-12-09	1996-06-25	West Agro, Inc.	Viscous liquid conditioning topical germicides
EP0971690B2 (de) *	1996-12-18	2015-04-01	Bimeda Research & Development Limited	Intramammäre tierarzneimittel ohne antiinfektiöse wirkstoffe
US6030633A (en)	1998-05-18	2000-02-29	West Agro, Inc.	Film-forming compositions for protecting animal skin
US20030060414A1 (en) †	2001-09-10	2003-03-27	Mchardy Nicholas	Bio-security system

2002
- 2002-12-20 GB GBGB0229642.4A patent/GB0229642D0/en not_active Ceased
2003
- 2003-12-08 AU AU2003283757A patent/AU2003283757C1/en not_active Expired
- 2003-12-08 JP JP2005510888A patent/JP2006515865A/ja active Pending
- 2003-12-08 NZ NZ541269A patent/NZ541269A/en not_active IP Right Cessation
- 2003-12-08 WO PCT/IB2003/005825 patent/WO2005051352A1/en not_active Ceased
- 2003-12-08 ES ES03775738T patent/ES2369769T5/es not_active Expired - Lifetime
- 2003-12-08 AT AT03775738T patent/ATE521336T1/de not_active IP Right Cessation
- 2003-12-08 CA CA002517622A patent/CA2517622C/en not_active Expired - Lifetime
- 2003-12-08 EP EP03775738.2A patent/EP1581184B2/de not_active Expired - Lifetime
- 2003-12-16 TW TW092135590A patent/TW200423927A/zh unknown
- 2003-12-19 MY MYPI20034900A patent/MY142767A/en unknown
2010
- 2010-04-21 AU AU2010201587A patent/AU2010201587A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2006515865A (ja)	2006-06-08
EP1581184B8 (de)	2013-09-04
CA2517622A1 (en)	2005-06-09
EP1581184B1 (de)	2011-08-24
EP1581184B2 (de)	2020-09-09
WO2005051352A8 (en)	2013-02-07
WO2005051352A1 (en)	2005-06-09
GB0229642D0 (en)	2003-01-22
MY142767A (en)	2010-12-31
AU2010201587A1 (en)	2010-05-13
TW200423927A (en)	2004-11-16
CA2517622C (en)	2009-04-07
AU2003283757C1 (en)	2014-05-01
NZ541269A (en)	2008-12-24
ES2369769T3 (es)	2011-12-05
EP1581184A1 (de)	2005-10-05
ES2369769T5 (es)	2021-06-09
AU2003283757B2 (en)	2010-01-21
AU2003283757A1 (en)	2005-06-17

Similar Documents

Publication	Publication Date	Title
MXPA02002249A (es)	2004-07-30	Composiciones farmaceuticas agradables al paladar para animales de compania.
ATE396973T1 (de)	2008-06-15	Benzylether- und benzylamino-beta-sekretase- hemmer zur behandlung von alzheimer-krankheit
EP1562897A4 (de)	2007-06-27	Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
ATE486587T1 (de)	2010-11-15	Formulierungen zur oralen verabreichung von wirkstoffen
NO20072864L (no)	2007-06-05	En transmukosal veterinaersammensetning som omfatter detomidin
ATE337777T1 (de)	2006-09-15	Zusammensetzung zur behandlung von huf- und klauenerkrankungen
ATE396967T1 (de)	2008-06-15	(5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
HUP0303840A2 (hu)	2004-03-29	Dermálisan alkalmazható folyékony készítmények állatokon élősködő rovarok leküzdésére
EP1689713A4 (de)	2009-02-18	Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
MA27867A1 (fr)	2006-05-02	Nouveaux derives de 2h-pyridazine-3-one, compositions pharmaceutiques contenant ces derives et procede de preparation de l'ingredient actif.
US20160030398A1 (en)	2016-02-04	Veterinary compositions for treating mastitis
ATE412646T1 (de)	2008-11-15	Zur behandlung von schmerzen geeignete therapeutische mittel
EP2982369A1 (de)	2016-02-10	Präparat zur behandlung von entzündungen bei pferden
DE60018545D1 (de)	2005-04-14	Zusammensetzung zur Behandlung von degenerativen Gelenkerkrankungen
ATE521336T1 (de)	2011-09-15	Zusammensetzungen zur tierärztlichen behandlung von mastitis
GT199800140A (es)	2000-02-29	Composicion farmaceutica antimastitica a base de extractos de origen natural y procedimientos para fabricarla.
ATE110714T1 (de)	1994-09-15	Derivate von hydroxaminsäure die lipoxygenase hemmen.
DE60217292D1 (de)	2007-02-15	Veterinärmedizinische dermatologische zusammensetzung
FR2887150B1 (fr)	2007-08-03	Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
BR0309768A (pt)	2005-03-22	Composições lubrificantes anidras de aquecimento e não-irritantes
AR029829A1 (es)	2003-07-16	Uso de un derivado de la caseina para la preparacion de composiciones cosmeticas, farmaceuticas y veterinarias y las composiciones asi preparadas, utiles para inhibir la adhesion de la flora patogenica a la piel
PT1100463E (pt)	2002-12-31	Novas formulacoes injectaveis contendo ramoplanina
NZ755538A (en)	2024-12-20	Antiparasitic isoxazoline compounds, long-acting injectable formulations comprising them, methods and uses thereof
UY28095A1 (es)	2004-06-30	Composición farmacéutica
FR2750333B1 (fr)	1998-12-04	1-0-alkyglycerols a usage pharmaceutique ou veterinaire

Legal Events

Date	Code	Title	Description
2012-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties